189 related articles for article (PubMed ID: 31332747)
1. Efficient Production of Homogeneous Lysine-Based Antibody Conjugates Using Microbial Transglutaminase.
Spidel JL; Albone EF
Methods Mol Biol; 2019; 2033():53-65. PubMed ID: 31332747
[TBL] [Abstract][Full Text] [Related]
2. Site-Specific Conjugation to Native and Engineered Lysines in Human Immunoglobulins by Microbial Transglutaminase.
Spidel JL; Vaessen B; Albone EF; Cheng X; Verdi A; Kline JB
Bioconjug Chem; 2017 Sep; 28(9):2471-2484. PubMed ID: 28820579
[TBL] [Abstract][Full Text] [Related]
3. Efficient Site-Specific Antibody-Drug Conjugation by Engineering a Nature-Derived Recognition Tag for Microbial Transglutaminase.
Ebenig A; Juettner NE; Deweid L; Avrutina O; Fuchsbauer HL; Kolmar H
Chembiochem; 2019 Sep; 20(18):2411-2419. PubMed ID: 31044494
[TBL] [Abstract][Full Text] [Related]
4. Site-Specific Conjugation of Native Antibodies Using Engineered Microbial Transglutaminases.
Dickgiesser S; Rieker M; Mueller-Pompalla D; Schröter C; Tonillo J; Warszawski S; Raab-Westphal S; Kühn S; Knehans T; Könning D; Dotterweich J; Betz UAK; Anderl J; Hecht S; Rasche N
Bioconjug Chem; 2020 Apr; 31(4):1070-1076. PubMed ID: 32134638
[TBL] [Abstract][Full Text] [Related]
5. Investigation of High Molecular Weight Size Variant Formation in Antibody-Drug Conjugates: Microbial Transglutaminase-Mediated Crosslinking.
Zhao Y; Kim S; Zheng X; Kim SH; Han A; Chen TH; Wang S; Zhong J; Qiu H; Li N
J Pharm Sci; 2023 Oct; 112(10):2629-2636. PubMed ID: 37586591
[TBL] [Abstract][Full Text] [Related]
6. Engineered, highly reactive substrates of microbial transglutaminase enable protein labeling within various secondary structure elements.
Rachel NM; Quaglia D; Lévesque É; Charette AB; Pelletier JN
Protein Sci; 2017 Nov; 26(11):2268-2279. PubMed ID: 28857311
[TBL] [Abstract][Full Text] [Related]
7. Illuminating structure and acyl donor sites of a physiological transglutaminase substrate from Streptomyces mobaraensis.
Juettner NE; Schmelz S; Bogen JP; Happel D; Fessner WD; Pfeifer F; Fuchsbauer HL; Scrima A
Protein Sci; 2018 May; 27(5):910-922. PubMed ID: 29430769
[TBL] [Abstract][Full Text] [Related]
8. Site-Specific Antibody-Drug Conjugation Using Microbial Transglutaminase.
Dickgiesser S; Deweid L; Kellner R; Kolmar H; Rasche N
Methods Mol Biol; 2019; 2012():135-149. PubMed ID: 31161507
[TBL] [Abstract][Full Text] [Related]
9. A recent update on the use of microbial transglutaminase for the generation of biotherapeutics.
Doti N; Caporale A; Monti A; Sandomenico A; Selis F; Ruvo M
World J Microbiol Biotechnol; 2020 Mar; 36(4):53. PubMed ID: 32172335
[TBL] [Abstract][Full Text] [Related]
10. Engineering THIOMABs for site-specific conjugation of thiol-reactive linkers.
Bhakta S; Raab H; Junutula JR
Methods Mol Biol; 2013; 1045():189-203. PubMed ID: 23913148
[TBL] [Abstract][Full Text] [Related]
11. Recent progress in transglutaminase-mediated assembly of antibody-drug conjugates.
Schneider H; Deweid L; Avrutina O; Kolmar H
Anal Biochem; 2020 Apr; 595():113615. PubMed ID: 32035039
[TBL] [Abstract][Full Text] [Related]
12. Directed Evolution of a Bond-Forming Enzyme: Ultrahigh-Throughput Screening of Microbial Transglutaminase Using Yeast Surface Display.
Deweid L; Neureiter L; Englert S; Schneider H; Deweid J; Yanakieva D; Sturm J; Bitsch S; Christmann A; Avrutina O; Fuchsbauer HL; Kolmar H
Chemistry; 2018 Oct; 24(57):15195-15200. PubMed ID: 30047596
[TBL] [Abstract][Full Text] [Related]
13. Engineering Antibodies with C-Terminal Sortase-Mediated Modification for Targeted Nanomedicine.
Hashad RA; Lange JL; Tan NCW; Alt K; Hagemeyer CE
Methods Mol Biol; 2019; 2033():67-80. PubMed ID: 31332748
[TBL] [Abstract][Full Text] [Related]
14. Engineering Dual Variable Domains for the Generation of Site-Specific Antibody-Drug Conjugates.
Nanna AR; Rader C
Methods Mol Biol; 2019; 2033():39-52. PubMed ID: 31332746
[TBL] [Abstract][Full Text] [Related]
15. Identification of preferred substrate sequences of microbial transglutaminase from Streptomyces mobaraensis using a phage-displayed peptide library.
Sugimura Y; Yokoyama K; Nio N; Maki M; Hitomi K
Arch Biochem Biophys; 2008 Sep; 477(2):379-83. PubMed ID: 18616926
[TBL] [Abstract][Full Text] [Related]
16. Continuous enzyme-coupled assay for microbial transglutaminase activity.
Oteng-Pabi SK; Keillor JW
Anal Biochem; 2013 Oct; 441(2):169-73. PubMed ID: 23877008
[TBL] [Abstract][Full Text] [Related]
17. Advances in the Development of Site-Specific Antibody-Drug Conjugation.
Zhou Q; Kim J
Anticancer Agents Med Chem; 2015; 15(7):828-36. PubMed ID: 25731178
[TBL] [Abstract][Full Text] [Related]
18. Transglutaminase-Mediated Conjugations.
Anami Y; Tsuchikama K
Methods Mol Biol; 2020; 2078():71-82. PubMed ID: 31643050
[TBL] [Abstract][Full Text] [Related]
19. Transglutaminase-based chemo-enzymatic conjugation approach yields homogeneous antibody-drug conjugates.
Dennler P; Chiotellis A; Fischer E; Brégeon D; Belmant C; Gauthier L; Lhospice F; Romagne F; Schibli R
Bioconjug Chem; 2014 Mar; 25(3):569-78. PubMed ID: 24483299
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic conjugation using branched linkers for constructing homogeneous antibody-drug conjugates with high potency.
Anami Y; Xiong W; Gui X; Deng M; Zhang CC; Zhang N; An Z; Tsuchikama K
Org Biomol Chem; 2017 Jul; 15(26):5635-5642. PubMed ID: 28649690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
